DUPILUMAB (Dupixent®)

Clinical Indication

For Treating Severe Chronic Rhinosinusitis with Nasal polyps

Comments

As per NICE TA1134

Funding: 18th May 2026

Date of classification

April 2026

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.